Literature DB >> 16005115

Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID).

Parastoo Momeni1, Nigel J Cairns, Robert H Perry, Eileen H Bigio, Marla Gearing, Andrew B Singleton, John Hardy.   

Abstract

Abnormal neuronal aggregates of alpha-internexin and the three neurofilament (NF) subunits, NFL, NFM, and NFH have recently been identified as the signature lesions of neuronal intermediate filament (IF) inclusion disease (NIFID), a novel neurological disease of early onset with a variable clinical phenotype including frontotemporal dementia, pyramidal and extrapyramidal signs. In other neurodegenerative diseases in which protein aggregates contribute to disease pathogenesis, mutations in the encoding protein cause the hereditary variant of the disease. To determine the molecular genetic contribution to this disease we performed a mutation analysis of all type IV neuronal IF, SOD1 and NUDEL genes in cases of NIFID and unaffected control cases. We found no pathogenic variants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005115     DOI: 10.1016/j.neurobiolaging.2005.03.030

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

Review 1.  Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.

Authors:  Ram K Sihag; Masaki Inagaki; Tomoya Yamaguchi; Thomas B Shea; Harish C Pant
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

Review 2.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

3.  Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease.

Authors:  Manuela Neumann; Sigrun Roeber; Hans A Kretzschmar; Rosa Rademakers; Matt Baker; Ian R A Mackenzie
Journal:  Acta Neuropathol       Date:  2009-08-09       Impact factor: 17.088

4.  FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy.

Authors:  Tristan Page; Michael A Gitcho; Sabrina Mosaheb; Deborah Carter; Sumi Chakraverty; Robert H Perry; Eileen H Bigio; Marla Gearing; Isidre Ferrer; Alison M Goate; Nigel J Cairns; Julian R Thorpe
Journal:  J Mol Neurosci       Date:  2011-05-21       Impact factor: 3.444

Review 5.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

6.  Gigaxonin mutation analysis in patients with NIFID.

Authors:  Florence Dequen; Nigel J Cairns; Eileen H Bigio; Jean-Pierre Julien
Journal:  Neurobiol Aging       Date:  2009-09-26       Impact factor: 4.673

7.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

8.  Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD.

Authors:  Parastoo Momeni; Jennifer Schymick; Shushant Jain; Mark R Cookson; Nigel J Cairns; Elisa Greggio; Matthew J Greenway; Stephen Berger; Stuart Pickering-Brown; Adriano Chiò; Hon Chung Fung; David M Holtzman; Edward D Huey; Eric M Wassermann; Jennifer Adamson; Michael L Hutton; Ekaterina Rogaeva; Peter St George-Hyslop; Jeffrey D Rothstein; Orla Hardiman; Jordan Grafman; Andrew Singleton; John Hardy; Bryan J Traynor
Journal:  BMC Neurol       Date:  2006-12-13       Impact factor: 2.474

Review 9.  Neurofilament proteins in axonal regeneration and neurodegenerative diseases.

Authors:  Haitao Wang; Minfei Wu; Chuanjun Zhan; Enyuan Ma; Maoguang Yang; Xiaoyu Yang; Yingpu Li
Journal:  Neural Regen Res       Date:  2012-03-15       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.